Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05580666 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Reducing Mortality in Adults With Advanced HIV Disease (REVIVE)

Study acronym: REVIVE
StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary completion date: May 31, 2028 to Nov 30, 2028 Study sites: 45 to 52 · Completion date: Aug 1, 2028 to May 31, 2029v6 Show 2 more changesShow less
    • Study sites: 45 to 52
    • Completion date: Aug 1, 2028 to May 31, 2029
  2. Re-verified, no change to tracked fieldsv5
  3. Primary completion date: Aug 31, 2026 to May 31, 2028 Study sites: 2 to 45 · Completion date: Dec 31, 2026 to Aug 1, 2028 · Eligibility criteria expanded, about 11 words · 1 morev4 Show 4 more changesShow less
    • Study sites: 2 to 45
    • Completion date: Dec 31, 2026 to Aug 1, 2028
    • Eligibility criteria expanded, about 11 words
    • Study description expanded, about 8 words

    See this version in full on ClinicalTrials.gov ↗

  4. Trial status: Not Yet Recruiting to Recruiting Start date changed from estimate of Apr 24, 2023 to May 8, 2023v3 Show 1 more changeShow less
    • Start date changed from estimate of Apr 24, 2023 to May 8, 2023
  5. Start date: Feb 2023 to Apr 24, 2023v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A double blinded, placebo-controlled, multicenter trial to evaluate effectiveness of azithromycin prophylaxis on mortality in advanced HIV.
Trial Details
NCT Number NCT05580666
Lead Sponsor Population Health Research Institute
Conditions HIV Disease Progression
Enrollment 8,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov